Most Recent
French drug giant Sanofi has appealed a decision giving American biopharmaceutical company Amgen the go-ahead for its patents for a cholesterol-lowering antibody that could be used to treat heart disease, diabetes, stroke and Alzheimer’s.
A consortium of parmigiano reggiano producers who claim Kraft Foods' 'Kraft parmesan cheese' trade will lead customers to believe the food giant's cheese is made in Italy have taken their fight to the Federal Court.
US-based mozzarella giant Leprino Foods has succeeded in removing Canadian dairy company Saputo's 'Ascend' trade mark for non-use.
A consortium of parmigiano reggiano producers has lost its challenge to Kraft Foods’ 'Kraft parmesan cheese' trade mark after an IP Australia delegate found that customers would be “sceptical” that the product was Italian.
A judge has refused a bid by manufacturer Howden to use an expert report before IP Australia in a dispute accusing rival Minetek of misappropriating confidential information for an industrial fan patent, saying it was “wasteful” when a similar dispute was already before the court.
A judge has found mining tool company Globaltech and mineral exploration company Boart Longyear infringed a patent for a mining tool owned by Australian Mud Company.
US-based multinational firm Jones Day has lured a partner from Clayton Utz to join its intellectual property team in Melbourne.
A judge has dismissed the majority of Microsoft’s six-year-old intellectual property suit against a Melbourne computer retailer over its Windows 7 software, which previously netted the Silicon Valley giant a $2.8 million payout from Judge Sandy Street that was slammed as a "regrettable" judicial failure.
Cable TV giant Foxtel has lost a protracted IP battle with subsidiary of global tech giant Cognizant over a digital download patent for a modern DVR system.
A judge has thrown out competing appeals of a decision finding Pfizer's patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.